Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Drug Price Control Order
Government Offers Interest Waiver If Pharma Companies Agree To Pay Rs 3,500 Crore, Drop All 666 Lawsuits
Swarajya Staff
May 9, 2019 11:44 AM +05:30 IST
In A First, Kerala Sets Up Drug Price Monitoring And Research Unit To Curb Overcharging Of Medicines
Swarajya Staff
Feb 3, 2019 01:05 PM +05:30 IST
Incentivising Innovation: No Price Controls On New Drugs For First Five Years
Swarajya Staff
Jan 4, 2019 10:59 AM +05:30 IST
Indian Stents ‘Equally Good’ As The Best In The Market, Study Rubbishes Claims Of Superiority By Foreign Manufacturers
Swarajya Staff
Nov 16, 2018 12:17 PM +05:30 IST
Dilemma Of The Draft Pharma Policy: To Protect The Consumer Or Promote Industry?
Ananya Awasthi
Sep 12, 2017 12:13 PM +05:30 IST
Load More